Superior Vena Cava Resection and Reconstruction in Thoracic Malignancy / 대한흉부외과학회지
The Korean Journal of Thoracic and Cardiovascular Surgery
; : 273-279, 2010.
Article
in Korean
| WPRIM (Western Pacific)
| ID: wpr-223920
Responsible library:
WPRO
ABSTRACT
BACKGROUND:
The benefit of superior vena cava (SVC) resection in thoracic malignancies remains controversial. We analyzed the results of extended resection in patients with thoracic malignancy involving the SVC. MATERIAL ANDMETHOD:
From March 2000 to March 2009, we performed surgical resection and reconstruction in 18 thoracic malignancies involving the SVC. Ten male and 8 female enrolled and their mean age was 56 years.RESULT:
SVC reconstruction was performed in 9 patients with polytetrafluoroethylene (PTFE) graft. Primary closure was possible in 6 patients by partially clamping the SVC. Patch angioplasty was performed in 3 patients with PTFE or autologous pericardial patch. Three-year survival was 58.0% and median survival time was 24.5 months. Disease specific survival and recurrence free survival were not significantly different between lung cancer and mediastinal malignancy. Obstruction of graft was detected in 4 patients during follow-up; SVC graft obstruction in 1 patient, and accessory graft between the innominate vein and right atrium in 3 patients.CONCLUSION:
Extended resection of thoracic malignancies involving the SVC was a feasible method in selected patients. Although the morbidity rate was relatively high, mid-term survival was acceptable when complete resection was possible.
Full text:
Available
Database:
WPRIM (Western Pacific)
Main subject:
Polytetrafluoroethylene
/
Recurrence
/
Vena Cava, Superior
/
Brachiocephalic Veins
/
Angioplasty
/
Constriction
/
Transplants
/
Heart Atria
/
Lung Neoplasms
/
Mediastinal Neoplasms
Limits:
Female
/
Humans
/
Male
Language:
Korean
Journal:
The Korean Journal of Thoracic and Cardiovascular Surgery
Year:
2010
Document type:
Article